BG Medicine, Inc. (BGMD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Envestnet Revenue
In the year 2015, BG Medicine had annual revenue of $1.57M, down -43.81%. BG Medicine had revenue of $290.00K in the quarter ending December 31, 2015, a decrease of -47.65%.
Revenue
1.57M
Revenue Growth
-43.81%
P/S Ratio
0.00
Revenue / Employee
313.20K
Employees
5
Market Cap
11.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2015 | 1.57M | -1.22M | -43.81% |
Dec 31, 2014 | 2.79M | -1.29M | -31.57% |
Dec 31, 2013 | 4.07M | 1.26M | 44.69% |
Dec 31, 2012 | 2.82M | 1.18M | 72.28% |
Dec 31, 2011 | 1.63M | 815.00K | 99.51% |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |